BGLC - BioNexus Gene Lab Corp
2.5
-0.080 -3.200%
Share volume: 5,706
Last Updated: 03-06-2026
Healthcare/Services – Health:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.58
-0.08
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-15-2024 | 05-15-2025 | 11-14-2025 | |
| Cash flow financing | 24.219 K | 173.580 K | -199.411 K | -860.000 | 34.187 K | |
| Other financing cash flows | 0.000 | 0.000 | -196.982 K | -860.000 | 0.000 | |
| Cash flow | 13.875 K | -413.898 K | -1.842 M | -840.578 K | -208.632 K | |
| Net income | -103.757 K | 199.104 K | -1.345 M | -543.079 K | -708.991 K | |
| Depreciation | 20.138 K | 20.205 K | 34.268 K | 26.642 K | 29.001 K | |
| Changes in inventories | -60.817 K | 0.000 | 0.000 | 209.480 K | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 24.098 K | 83.062 K | -183.116 K | -15.646 K | 994.646 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | -174.247 K | 227.670 K | 85.017 K | 6.594 K | -11.680 K | |
| Dividends Paid | -2.711 K | -1.834 K | -2.429 K | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 9.052 K | 5.483 K | |
| Cash Change | -97.155 K | -418.148 K | -1.277 M | -617.932 K | 78.173 K |